L‑Methylfolate Adjunct Therapy Enhances Symptoms and Cognitive Function in Treated Psychiatric Patients

(MedPage Today) — In treatment‑experienced psychiatric patients receiving established pharmacotherapy, adjunctive L‑methylfolate (Deplin) was linked with significant reductions in overall symptom burden and improvements in executive function.

What's Hot

Sand cliff collapses onto tents in Gaza, killing 5

Pope Leo XIV Concludes Uruguay Visit with Tribute to Women Before Heading to Argentina

BBC pundit identifies three major Manchester United problems that go beyond Michael Carrick

L‑Methylfolate Adjunct Therapy Enhances Symptoms and Cognitive Function in Treated Psychiatric Patients

Endoscopic Surgery Resolves 19-Year Case of Bobble-Head Doll Syndrome Caused by Giant Posterior Fossa Cyst

Lost in the Labyrinth of Nicotine Products

STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype

One-Day Fast Boosts Gut Repair via Key Bacterium, Study Finds

A Woman’s Arm Jerked Only When She Put On Lipstick, Months After a Fall Hurt Her Shoulder

Texture-Specific Pharyngeal Dystonia Identified in Rare Case Reports

What's Hot

L‑Methylfolate Adjunct Therapy Enhances Symptoms and Cognitive Function in Treated Psychiatric Patients

Also Read

Keep Reading

Subscribe to Updates